Free Trial

NeoGenomics (NEO) Earnings Date, Estimates & Call Transcripts

NeoGenomics logo
$17.28 +0.13 (+0.76%)
(As of 03:03 PM ET)

NeoGenomics Latest Earnings Summary

Actual EPS
(Nov. 5)
$0.05 Beat By $0.04
Consensus EPS
(Nov. 5)
$0.01

NeoGenomics released Q3 2024 earnings on November 5, 2024, reporting an EPS of $0.05, which beat the consensus estimate of $0.01 by $0.04. Quarterly revenue rose 10.5% year-over-year to $167.80 million, above the consensus estimate of $167 million. With a trailing EPS of -$0.61, NeoGenomics' earnings are expected to grow next year, from ($0.16) to ($0.06) per share.

Get NeoGenomics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeoGenomics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NEO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NEO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NeoGenomics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242-$0.13-$0.08-$0.11 
Q2 20242-$0.11-$0.04-$0.08 
Q3 20242-$0.08-$0.04-$0.06 
Q4 20243-$0.07-$0.05-$0.06 
FY 20249-$0.39-$0.21-$0.30 
Q1 20252-$0.07-$0.03-$0.05 
Q2 20252-$0.06-$0.02-$0.04 
Q3 20252-$0.05-$0.01-$0.03 
Q4 20251-$0.01-$0.01-$0.01 
FY 20257($0.19)($0.07) ($0.13)

NeoGenomics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2024Q3 2024$0.01$0.05+$0.04$0.10$167.00M$167.80M
7/29/2024Q2 2024-$0.0020$0.03+$0.0320$0.07$161.82M$164.50M
4/30/2024Q1 2024-$0.07-$0.08 -$0.01$0.05$149.82M$156.24M
2/20/2024Q4 2023-$0.07-$0.02+$0.05$0.07$152.90M$155.55M
11/6/2023Q3 2023-$0.11-$0.06+$0.05$0.03$142.15M$151.95M
8/8/2023Q2 2023-$0.15-$0.09+$0.06$0.01$138.22M$146.92M
5/8/2023Q1 2023-$0.16-$0.13+$0.03-$0.01$126.31M$137.22M
2/23/2023Q4 2022-$0.19-$0.10+$0.09-$0.02$129.96M$138.71M

NeoGenomics Earnings - Frequently Asked Questions

NeoGenomics (NASDAQ:NEO) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on NEO's earnings history.

NeoGenomics updated its FY 2024 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of 0.080-0.100 for the period, compared to the consensus earnings per share estimate of 0.060. The company issued revenue guidance of $655.0 million-$667.0 million, compared to the consensus revenue estimate of $661.7 million.

In the previous quarter, NeoGenomics (NASDAQ:NEO) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.04. Learn more on analysts' earnings estimate vs. NEO's actual earnings.

The conference call for NeoGenomics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for NeoGenomics's latest earnings report can be read online.
Read Transcript

NeoGenomics's earnings report can be found in their filing with the SEC.
View SEC filing

NeoGenomics (NASDAQ:NEO) has a recorded annual revenue of $644.12 million.

NeoGenomics (NASDAQ:NEO) has a recorded net income of -$87.97 million. NEO has generated -$0.61 earnings per share over the last four quarters.

NeoGenomics's earnings are expected to grow from ($0.16) per share to ($0.06) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NEO) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners